312 related articles for article (PubMed ID: 14999492)
21. A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex.
MacLeod H; Pytel P; Wollmann R; Chelmicka-Schorr E; Silver K; Anderson RB; Waggoner D; McNally EM
Neuromuscul Disord; 2007 Apr; 17(4):285-9. PubMed ID: 17336067
[TBL] [Abstract][Full Text] [Related]
22. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.
Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M
J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738
[TBL] [Abstract][Full Text] [Related]
23. Late-onset autosomal recessive limb-girdle muscular dystrophy with rimmed vacuoles.
Nakamura A; Yoshida K; Ikeda S
Clin Neurol Neurosurg; 2004 Mar; 106(2):122-8. PubMed ID: 15003303
[TBL] [Abstract][Full Text] [Related]
24. Co-occurrence of mutations in both dystrophin- and androgen-receptor genes is a novel cause of female Duchenne muscular dystrophy.
Katayama Y; Tran VK; Hoan NT; Zhang Z; Goji K; Yagi M; Takeshima Y; Saiki K; Nhan NT; Matsuo M
Hum Genet; 2006 Jun; 119(5):516-9. PubMed ID: 16528518
[TBL] [Abstract][Full Text] [Related]
25. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
26. The muscular dystrophies.
Flanigan KM
Semin Neurol; 2012 Jul; 32(3):255-63. PubMed ID: 23117950
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry in the diagnosis of dystrophinopathies.
Manole E
Rom J Neurol Psychiatry; 1995; 33(1):51-5. PubMed ID: 7547371
[TBL] [Abstract][Full Text] [Related]
28. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
29. PGD for dystrophin gene deletions using fluorescence in situ hybridization.
Malmgren H; White I; Johansson S; Levkov L; Iwarsson E; Fridström M; Blennow E
Mol Hum Reprod; 2006 May; 12(5):353-6. PubMed ID: 16608904
[TBL] [Abstract][Full Text] [Related]
30. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene.
Nakamura A; Yoshida K; Fukushima K; Ueda H; Urasawa N; Koyama J; Yazaki Y; Yazaki M; Sakai T; Haruta S; Takeda S; Ikeda S
J Clin Neurosci; 2008 Jul; 15(7):757-63. PubMed ID: 18261911
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic strategies for Duchenne and Becker dystrophies.
Voisin V; de la Porte S
Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
[TBL] [Abstract][Full Text] [Related]
33. Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families.
Elhawary NA; Shawky RM; Hashem N
Mol Cells; 2004 Oct; 18(2):141-9. PubMed ID: 15528988
[TBL] [Abstract][Full Text] [Related]
34. Dystrophin gene analysis in Hungarian Duchenne/Becker muscular dystrophy families - detection of carrier status in symptomatic and asymptomatic female relatives.
Pikó H; Vancsó V; Nagy B; Bán Z; Herczegfalvi A; Karcagi V
Neuromuscul Disord; 2009 Feb; 19(2):108-12. PubMed ID: 19084397
[TBL] [Abstract][Full Text] [Related]
35. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
Arikawa E; Hoffman EP; Kaido M; Nonaka I; Sugita H; Arahata K
Neurology; 1991 Sep; 41(9):1491-6. PubMed ID: 1842672
[TBL] [Abstract][Full Text] [Related]
36. Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients.
Chelly J; Gilgenkrantz H; Hugnot JP; Hamard G; Lambert M; Récan D; Akli S; Cometto M; Kahn A; Kaplan JC
J Clin Invest; 1991 Oct; 88(4):1161-6. PubMed ID: 1918370
[TBL] [Abstract][Full Text] [Related]
37. [Muscular dystrophies with dystrophin glycoprotein complex deficit].
Dorobek M
Neurol Neurochir Pol; 1999; 33(6):1381-9. PubMed ID: 10791040
[TBL] [Abstract][Full Text] [Related]
38. Transcription of the dystrophin gene in human muscle and non-muscle tissue.
Chelly J; Kaplan JC; Maire P; Gautron S; Kahn A
Nature; 1988 Jun; 333(6176):858-60. PubMed ID: 3290682
[TBL] [Abstract][Full Text] [Related]
39. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis.
Cooper ST; Kizana E; Yates JD; Lo HP; Yang N; Wu ZH; Alexander IE; North KN
Neuromuscul Disord; 2007 Apr; 17(4):276-84. PubMed ID: 17303423
[TBL] [Abstract][Full Text] [Related]
40. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
